Expression of Concern: König, B.; Kirchner, J.O. Methodological Considerations Regarding the Quantification of DNA Impurities in the COVID-19 mRNA Vaccine Comirnaty®. Methods Protoc. 2024, 7, 41
References
- König, B.; Kirchner, J.O. Methodological Considerations Regarding the Quantification of DNA Impurities in the COVID-19 mRNA Vaccine Comirnaty®. Methods Protoc. 2024, 7, 41. [Google Scholar] [CrossRef] [PubMed]
- Kaiser, S.; Kaiser, S.; Reis, J.; Marschalek, R. Quantification of objective concentrations of DNA impurities in mRNA vaccines. Vaccine 2025, 55, 127022. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Methods and Protocols Editorial Office. Expression of Concern: König, B.; Kirchner, J.O. Methodological Considerations Regarding the Quantification of DNA Impurities in the COVID-19 mRNA Vaccine Comirnaty®. Methods Protoc. 2024, 7, 41. Methods Protoc. 2025, 8, 68. https://doi.org/10.3390/mps8040068
Methods and Protocols Editorial Office. Expression of Concern: König, B.; Kirchner, J.O. Methodological Considerations Regarding the Quantification of DNA Impurities in the COVID-19 mRNA Vaccine Comirnaty®. Methods Protoc. 2024, 7, 41. Methods and Protocols. 2025; 8(4):68. https://doi.org/10.3390/mps8040068
Chicago/Turabian StyleMethods and Protocols Editorial Office. 2025. "Expression of Concern: König, B.; Kirchner, J.O. Methodological Considerations Regarding the Quantification of DNA Impurities in the COVID-19 mRNA Vaccine Comirnaty®. Methods Protoc. 2024, 7, 41" Methods and Protocols 8, no. 4: 68. https://doi.org/10.3390/mps8040068
APA StyleMethods and Protocols Editorial Office. (2025). Expression of Concern: König, B.; Kirchner, J.O. Methodological Considerations Regarding the Quantification of DNA Impurities in the COVID-19 mRNA Vaccine Comirnaty®. Methods Protoc. 2024, 7, 41. Methods and Protocols, 8(4), 68. https://doi.org/10.3390/mps8040068